Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, July 10, 2009, 4:27AM ET - U.S. Markets open in 5 hours and 3 minutes. Dow Up 0.06% Nasdaq  0.00%
Angiotech Pharmaceuticals, Inc. (ANPI)On Jul 9: 1.43   0.00 (0.00%)  
MORE ON ANPI
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Thu, Jul 9, 2009
AnalystChoice.com Brings You the Best Complimentary Research Report on INFY, ANPI, SUSQ, ODFL, LSTR and CWTR
Marketwire (Thu 8:21am)
Mon, Jul 6, 2009
Angiotech Pharmaceuticals Earnings Call scheduled for Thu, Aug 6
CCBN (Mon, Jul 6)
Angiotech Pharmaceuticals, Inc. announces conference call and webcast
PR Newswire (Mon, Jul 6)
Medical Device Trades: 7 Stocks Under 5 Bucks
at Seeking Alpha (Mon, Jul 6)
Tue, Jun 16, 2009
5 Stocks Approaching Greatness
at Motley Fool (Tue, Jun 16)
Tue, Jun 9, 2009
4-Star Stocks on the Upswing
at Motley Fool (Tue, Jun 9)
[$$] Headwaters Is Off, but Piedmont Is On
at The Wall Street Journal Online (Tue, Jun 9)
Mon, Jun 8, 2009
[$$] Biotech and China Still Have Aggressive Trading
at RealMoney by TheStreet.com (Mon, Jun 8)
Angiotech says FDA approves embolism filter
AP (Mon, Jun 8)
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
PR Newswire (Mon, Jun 8)
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
CNW Group (Mon, Jun 8)
Wed, Jun 3, 2009
ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
EDGAR Online (Wed, Jun 3)
Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
PR Newswire (Wed, Jun 3)
Tue, Jun 2, 2009
10 Stocks to Shake the Market
at Motley Fool (Tue, Jun 2)
Wed, May 27, 2009
[video] Snacks Sell In Downturn
at Forbes.com (Wed, May 27)
4-Star Stocks on the Upswing
at Motley Fool (Wed, May 27)
Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberté(R) Atom(TM) Stent system
CNW Group (Wed, May 27)
Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
PR Newswire (Wed, May 27)
Wed, May 20, 2009
SYNTAX analysis finds treatment with TAXUS(R) Express(2)(R) Stent System more cost effective than bypass surgery in patients with complex coronary artery disease system
PR Newswire (Wed, May 20)
SYNTAX analysis finds treatment with TAXUS(R) Express(2)(R) Stent System more cost effective than bypass surgery in patients with complex coronary artery disease system
CNW Group (Wed, May 20)
Older Headlines - Download Recent Headlines
View headlines from:
Add ANPI News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage